Last reviewed · How we verify

NCT05023408

Intralesional Bleomycin Versus Cryotherapy for Treatment of Cutaneous Warts

Completed Phase 2 Last updated 26 August 2021
What this trial tests

Phase 2 trial testing Bleomycin Injection in Cutaneous Warts in 154 participants. Completed in 30 June 2021.

Timeline
1 January 2021
Primary endpoint
30 June 2021
30 June 2021

Quick facts

Lead sponsorJinnah Postgraduate Medical Centre
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment154
Start date1 January 2021
Primary completion30 June 2021
Estimated completion30 June 2021
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Jinnah Postgraduate Medical Centre — full company profile →

Who can join

Adults 18 to 60, any sex, with Cutaneous Warts. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study was to determine the efficacy of intralesional bleomycin in comparison to cryotherapy on participants having cutaneous warts.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Bleomycin Injection

Trials testing the same drug.

Other Jinnah Postgraduate Medical Centre trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05023408.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing